<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">Arq. Bras. Cardiol.</journal-id>
      <journal-title-group>
        <journal-title>Arquivos brasileiros de cardiologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23917511</article-id>
      <article-id pub-id-type="pmc">3998171</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20130134</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Anatomopathological Session</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case 3 - Congestive Heart Failure in Male with Systemic
Sclerosis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zanetti</surname>
            <given-names>Caio Bosquiero</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lopes</surname>
            <given-names>Mariana Bittar</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lyrio</surname>
            <given-names>Andr&#xE9; Marun</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Campos</surname>
            <given-names>Pompeu Ribeiro</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bonfiglioli</surname>
            <given-names>Rubens</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Teixeira</surname>
            <given-names>Maria Aparecida Barone</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <aff id="a01">Grupo de Estudos em Correla&#xE7;&#xE3;o Anatomocl&#xED;nica (GECAC), Faculdade de
Medicina da Pontif&#xED;cia Universidade Cat&#xF3;lica de Campinas, Campinas, SP - Brazil
</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Maria Aparecida Barone Teixeira</bold>, Grupo de Estudos em
Correla&#xE7;&#xE3;o An&#xE1;tomo Cl&#xED;nica - GECAC, Faculdade de Medicina da PUC-Campinas, Av. John
Boyd Dunlop, s/n - Campinas - SP. Postal Code 13060-803, E-mail:
<email>cidinha@puc-campinas.edu.br</email></corresp>
        <fn id="fn01" fn-type="other">
          <p><bold>Section Editor:</bold> Alfredo Jos&#xE9; Mansur (ajmansur@incor.usp.br)</p>
        </fn>
        <fn id="fn02" fn-type="other">
          <p><bold>Associated Editors:</bold> Desid&#xE9;rio Favarato (dclfavarato@incor.usp.br)</p>
          <p>Vera Demarchi Aiello (anpvera@incor.usp.br)</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2013</year>
      </pub-date>
      <volume>101</volume>
      <issue>1</issue>
      <fpage>e01</fpage>
      <lpage>e07</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Heart Failure</kwd>
        <kwd>Scleroderma, Systemic</kwd>
        <kwd>Pulmonary Fibrosis</kwd>
        <kwd>Pericarditis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>71 year-old Caucasian male, resident of Campinas - SP, diagnosed with diffuse systemic
sclerosis, with clinical condition initiated by skin stiffening in lower limbs for seven
months, which spread three months ago to the upper limbs (hands and forearms) and, one
month ago, to chest and abdomen; in addition to confirmatory laboratory exams, such as the
research of anti-nuclear factor reagent in 1:640 titration with dense fine speckled pattern
and anti-topoisomerase antibodies I (Anti-Scl 70) also reagent, was under outpatient
follow-up at the service rheumatology sector. The patient had no other comorbities or
relevant medical history.</p>
    <p>In the occasion, he sought medical care and had progressive dyspnea during minor efforts,
edema on lower limbs and dry cough. This clinical condition began five months earlier.</p>
    <p>Physical exam showed good general state, with 92bpm heart rate and 80/60mmHg blood
pressure, 60&#xBA; jugular turgidity and peripheral perfusion unchanged.</p>
    <p>When examining the lungs, vesicular breath sounds was significantly reduced, with
velcro-type rales in both bases. Precordium and abdomen exams showed no changes.</p>
    <p>There was a severe skin tightening on hands and forearms, with limited movements,
contracture flexion and tendon retraction, giving the appearance of "claw hands", and
digital ulcers.</p>
    <p>Lower limbs showed the same skin severity level, also with movements limitation and edema
++/+4 on the distal 2/3. On the skin we noticed several pigmentary changes on hands,
forearms, chest and abdomen. However, skin biopsy was not performed.</p>
    <p>Chest computed tomography showed diffuse interstitial pulmonary fibrosis, characteristic of
usual interstitial pneumonia with subpleural involvement and regions with "ground glass"
appearance, in addition to distortion signs of the pulmonary parenchyma, with reticulate
and images that suggest bronchiectasis, specially in lower limbs (<xref ref-type="fig" rid="f01">Figure 1</xref>). On the mediastinal window there was a suggestive image of
pericardial thickening, in addition to a small amount of fluid (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
    <fig id="f01" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Chest CT showing a diffuse interstitial pulmonary fibrosis, with subpleural
involvement, honeycombing and bronchiectasis, characteristics of a usual pattern of
interstitial pneumonia.</p>
      </caption>
      <graphic xlink:href="abc-101-01-0e01-g01"/>
    </fig>
    <fig id="f02" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Chest CT demonstrating pericardial thickening and a small amount of fluid.</p>
      </caption>
      <graphic xlink:href="abc-101-01-0e01-g02"/>
    </fig>
    <p>In the electrocardiogram there was an atrial fibrillation rhythm, without further changes.
Echocardiogram measures are described on <xref ref-type="table" rid="t01">Table 1</xref>.
This exam also identified a mild mitral insufficiency, severe tricuspid insufficiency and
signs of severe pulmonary hypertension, being the systolic pressure in pulmonary artery
(SPPA) underestimated due to severe tricuspid reflux, with RV - RA gradient of 20mmHg.No
changes on pericardium were shown.</p>
    <table-wrap id="t01" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Measures obtained through echocardiogram, showing a moderate dilation on the left
atrium</p>
      </caption>
      <table frame="hsides" rules="rows">
        <thead>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>Analysis</bold>
            </td>
            <td align="center" rowspan="1" colspan="1">
              <bold>Measure</bold>
            </td>
            <td align="center" rowspan="1" colspan="1">
              <bold>Analysis</bold>
            </td>
            <td align="center" rowspan="1" colspan="1">
              <bold>Measure</bold>
            </td>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Aorta</td>
            <td align="center" rowspan="1" colspan="1">33.00mm</td>
            <td align="center" rowspan="1" colspan="1">LV - final systolic diameter</td>
            <td align="center" rowspan="1" colspan="1">21.00mm</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Left atrium</td>
            <td align="center" rowspan="1" colspan="1">48.00mm</td>
            <td align="center" rowspan="1" colspan="1">LV - final diastolic volume</td>
            <td align="center" rowspan="1" colspan="1">87.69mm</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Left atrium/aorta</td>
            <td align="center" rowspan="1" colspan="1">1.45mm</td>
            <td align="center" rowspan="1" colspan="1">LV - final systolic volume</td>
            <td align="center" rowspan="1" colspan="1">14.41mm</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Right ventricle</td>
            <td align="center" rowspan="1" colspan="1">30.00mm</td>
            <td align="center" rowspan="1" colspan="1">Shortening fraction</td>
            <td align="center" rowspan="1" colspan="1">52.27%</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Ventricular septum</td>
            <td align="center" rowspan="1" colspan="1">10.00mm</td>
            <td align="center" rowspan="1" colspan="1">Ejection fraction</td>
            <td align="center" rowspan="1" colspan="1">83.57%</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Posterior wall</td>
            <td align="center" rowspan="1" colspan="1">10.00mm</td>
            <td align="center" rowspan="1" colspan="1">LV mass</td>
            <td align="center" rowspan="1" colspan="1">147.24g</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">IV septum/posterior wall</td>
            <td align="center" rowspan="1" colspan="1">1.00mm</td>
            <td align="center" rowspan="1" colspan="1">LV mass index</td>
            <td align="center" rowspan="1" colspan="1">85.80g/m<sup>2</sup></td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">LV - diastolic diameter</td>
            <td align="center" rowspan="1" colspan="1">44.00mm</td>
            <td align="center" rowspan="1" colspan="1">V/M relation</td>
            <td align="center" rowspan="1" colspan="1">0.60</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>After 40 days of hospitalization, he showed a worsening clinical condition and a relevant
hemodynamic impairment, which resulted in cardiogenic shock and death.</p>
    <p>(Dr. Mariana Bittar Lopes; Academician Caio Bosquiero Zanetti)</p>
    <sec>
      <title>Clinical aspects</title>
      <p>The patient was a healthy male, without comorbities, who showed a diffuse systemic
sclerosis (DSS) condition at the age of 71. It is known that when this autoimmune
disease is manifested after the patient is 60 years old, it evolves more rapidly and,
therefore, has a worse prognostic<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r03" ref-type="bibr">3</xref></sup>. With the reported clinical condition, it
is hard to elaborate differential diagnosis, because in addition to symptoms and
clinical signs on his skin and articulations, immunological evidence were reagent and
are positive in 90% of DSS cases, specially anti-centromere antibodies,
anti-topoisomerase I and anti-RNA polymerase, which show a specificity of
97-100%<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r04" ref-type="bibr">4</xref>-<xref rid="r07" ref-type="bibr">7</xref></sup>.</p>
      <p>Diastolic congestive heart failure (DCHF), in this case, can be a result of the heart
impairment caused by DSS, for there are indications of constrictive pericarditis,
demonstrated by the pericardial thickening seen in chest computed tomography and left
atrium, seen on echocardiogram. DCHF could also be a consequence of the pulmonary
hypertension resulting from either the pneumopathy described or pulmonary endarteritis.
Atrial fibrillation can be justified by the myocardial impairment of DSS, as well as by
the tricuspid insufficiency resulting from the right chambers impairment caused by the
pulmonary hypertension.</p>
      <p>In this case, the pulmonary impairment pattern demonstrated by the chest computed
tomography is not the most common one in DSS. The most frequent is the non-specific
interstitial pneumonia<sup><xref rid="r08" ref-type="bibr">8</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup>. However, we cannot discard that the
pulmonary impairment identified is a result of chronic inflammatory changes in pulmonary
interstice caused by the disease, which are more active ("ground glass" pattern) and
already show older changes, such as pulmonary fibrosis which, by traction, induce
bronchiectasis and subpleural thickenings, classifying the tomographic findings as acute
exacerbation of the chronic evolution interstitial pneumonia, common on
collagenosis<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r11" ref-type="bibr">11</xref></sup>.</p>
      <p>The patient developed cardiogenic shock due to natural progression of heart disease,
which worsened due to chronic hypoxia resulting from lung disease or embolism or
thrombosis of pulmonary arteries.</p>
      <p>Thus, it is possible to suggest the following clinical diagnoses: diffuse systemic
sclerosis, diastolic congestive heart failure, chronic atrial fibrillation, constrictive
pericarditis secondary to DSS, pulmonary fibrosis secondary to DSS, pulmonary arterial
hypertension associated with DSS, bronchiectasis and cardiogenic shock. As clinical
hypotheses: diffuse systemic sclerosis, diastolic congestive heart failure, constrictive
pericarditis secondary to DSS, pulmonary arterial hypertension secondary to DSS,
pulmonary fibrosis secondary to DSS, chronic atrial fibrillation and cardiogenic
shock.</p>
      <p>(Dr. Maria Aparecida Barone Teixeira)</p>
    </sec>
    <sec>
      <title>Necropsy</title>
      <p>There was a relevant skin impairment described by the physical examination,
histologically revealed in several skin fragments examined, such as a significant
increase of compact collagen in dermis, thinning of epidermis, loss of interpapillary
crystals, hyperpigmentation of melanocytes, adnexal atrophy, hyaline thickening of
dermal arteriolar walls and perivascular and perianexial inflammatory process.</p>
      <p>There was a thickening of pericardial sac with high adherence between the parietal and
visceral pericardium, and only 17mL of bloody pericardial fluid. The microscopic study
revealed a severe fibrinous chronic pericarditis (<xref ref-type="fig" rid="f04">Figure
4</xref>). Right heart chambers and pulmonary trunk were dilated, in addition to the
dilation of tricuspid ring. Cross-section of the heart showed small fibrosis foci
distributed over the left ventricle, specially in subendocardial regions, histologically
identified as thick fibrous ridges, and high increase of interstitial collagen,
constantly changing the structure of muscle fibers (<xref ref-type="fig" rid="f05">Figure 5</xref> and <xref ref-type="fig" rid="f06">6</xref>). Moreover, throughout
the myocardium were identified moderate/severe hyperplastic arteriolosclerosis and areas
of degeneration and band necrosis of myocytes (<xref ref-type="fig" rid="f05">Figure
5</xref>), probably due to ischemic component associated with arteriolar disease,
common in diffuse systemic sclerosis.</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>(A) Cross-section showing pericardial thickening (arrow); (B) Severe fibrinous
chronic epicarditis (asterisks), eosin haematoxylin (EH) &#x2013; original magnification
100x.</p>
        </caption>
        <graphic xlink:href="abc-101-01-0e01-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Cut of subendocardial region with increased interstitial collagen and thick
fibrous ridge (arrows), changing the muscle fibers structure. Also note the
moderate/ severe hyperplastic arteriosclerosis and degeneration areas of myocytes
due to arteriolar disease, eosin haematoxylin (EH) &#x2013; original magnification 100x
(A and B).</p>
        </caption>
        <graphic xlink:href="abc-101-01-0e01-g05"/>
      </fig>
      <p>Lungs had increased consistency, moderate pleural thickening and were wine-colored,
which suggested venous congestion. When cutting, there was a severe fibrosis with
thickening of intralobular septa and increased airways, often converging and forming
cystic structures, leading to honeycombing. Histologically, pulmonary parenchyma showed
high thickening of alveolar septa due to conjunctive tissue, destruction of walls due to
increased airways, bronchiectasis and, predominantly, bronchioloectasia, in addition to
severe hyperplastic arteriosclerosis in all fragments, changes that characterize the
pulmonary involvement of the disease.</p>
      <p>Other organs did not show significant changes.</p>
      <p>Anatomopathological diagnosis: chronic fibrosing pericarditis, myocardial fibrosis,
myocardial arteriosclerosis, chronic passive pulmonary congestion, intralobular
pulmonary fibrosis, bronchiectasis and bronchioloectasia, and pulmonary
arteriosclerosis.</p>
      <p>(Dr. Pompeu Ribeiro de Campos)</p>
    </sec>
    <sec>
      <title>Clinical comment</title>
      <p>Firstly described by Carlos Curzio (Naples, 1753), Scleroderma, currently known by
Systemic Sclerosis (SS), is an chronic idiopathic inflammatory disease, characterized
primarily by proliferative endarteritis, and increased conjunctive tissue on skin and
internal organs, specially in lungs, gastrointestinal tract, heart, and kidneys. With
prevalence that varies from 30 - 290 cases per million inhabitants, usually begins
between the 3rd and 6th decade of life, and is more common in females with a proportion
ranging from 3 - 8 women for each man<sup><xref rid="r02" ref-type="bibr">2</xref></sup>.</p>
      <p>It can manifest itself in a limited way, basically restricted to skin in distal, or
diffuse, portions, affecting the skin not only distally, but also the face, trunk, and
abdomen, in addition to rapid progress and severe visceral impairment.</p>
      <p>Its pathogen is not completely clear, however, it is believed that there are
interactions between genetic factors and immunological changes involved in the
development of the disease. In principle, there is an increased activity of genetically
pre-determined T lymphocytes, which through inflammatory factors, such as interleukins 3
and 4, promote the mast cells degranulation. These mast cells cause the increased
significance of the growth factors of fibroblasts and endothelial cells. Thus, it is an
abnormal endothelial proliferation, specially in microcirculation, changes in
vasoreactivity, coagulation processes, and modulation of the growth of neighboring
cells, such as smooth muscle cells and fibroblasts, in addition to the large increase of
secretion of collagen types I, III, and VI, primarily by the action of Transforming
Growth Factor Beta (TGF-Beta), resulting in high process of fibrosis<sup><xref rid="r02" ref-type="bibr">2</xref></sup>.</p>
      <fig id="f06" orientation="portrait" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Increased conjunctive tissue between heart muscle fibers (asterisk) with presence
of fibroblasts (arrow), eosin haematoxylin (EH) &#x2013; original magnification 100x (A)
and 400x (B).</p>
        </caption>
        <graphic xlink:href="abc-101-01-0e01-g06"/>
      </fig>
      <p>As for the heart, the heart impairment in diffuse disease is found in 32% of
patients<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r12" ref-type="bibr">12</xref></sup>, and may involve the pericardium, coronary arteries,
conduction system, and myocardium, which is the most affected region<sup><xref rid="r13" ref-type="bibr">13</xref></sup>. Based on clinical criteria, the
prevalence of myocardiopathy varies between 20 - 25% of patients with DSS<sup><xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref></sup>, a number that can reach up to 70% of cases in necropsy
studies<sup><xref rid="r16" ref-type="bibr">16</xref></sup>. Anatomically, the
most common findings are band cell necrosis and foci of myocardial fibrosis, equally
distributed between the right and left ventricles and mainly involving subendocardial
regions. In functional terms, systolic left ventricle failure is most often subclinical,
reducing the ejection fraction by echocardiogram in only 11% of patients<sup><xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup>. Frank congestive heart
failure occurs in cases of advanced diseased, and right ventricular failure is most
often a result of pulmonary hypertension, both are factors of worse prognosis.</p>
      <p>Pericardial changes are found in 33 - 72% of necropsies<sup><xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r21" ref-type="bibr">21</xref></sup> and consist of
pericardial fibrosis, fibrinous pericarditis, pericardial adhesions and stroke. However,
clinical manifestations of the pericardial disease occur in only 7 - 20% of patients.
Small accumulation of pericardial fluid and chronic strokes are present in 35% of cases
by echocardiogram<sup><xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r22" ref-type="bibr">22</xref></sup>, generally asymptomatic, are related to pulmonary
hypertension<sup><xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref></sup> and, also, a
poor prognosis. We must also remember the concept of <italic>concretio cordis</italic>,
a rare heart manifestation of DSS, related to severe constrictive pericarditis resulting
from high fibrotic process, severe pericardial thickening and ectopic
calcifications<sup><xref rid="r25" ref-type="bibr">25</xref>,<xref rid="r26" ref-type="bibr">26</xref></sup>.</p>
      <p>Changes in epicardial coronary arteries are not common and the coronary atherosclerosis
is not related to DSS<sup><xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref></sup>. However, 40 - 70% of asymptomatic
patients have perfusion abnormalities at rest, identified by scintigraphy with
Thallium-201, and 38% have flow alterations induced by stress<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr"> 16</xref></sup>. Studies show
that such events are due to intimal proliferation, mural fibrosis, and endothelial
proliferation of intramural arteries and microcirculation, characterizing hyperplastic
arteriolosclerosis, common in DSS<sup><xref rid="r16" ref-type="bibr">16</xref></sup>.
Overall, evidence suggest abnormalities in vasoreactivity and transitory constrictions
in small arteries and arterioles, contributing to ischemic events of the myocardium.</p>
      <p>In addition to the aforementioned, are also factors of worse prognosis: rapid
progression of skin sclerosis, linked to early cardiac involvement in 41% of
cases<sup><xref rid="r12" ref-type="bibr">12</xref></sup>, cardiac involvement at
diagnosis, associated with a mean survival of 32 months<sup><xref rid="r16" ref-type="bibr">16</xref></sup>, and clinical manifestations resulting from heart
impairment, determining a death rate of up to 70% in five years<sup><xref rid="r13" ref-type="bibr">13</xref></sup>. Pulmonary involvement, wither pulmonary
hypertension or restrictive pulmonary disease, defines a mean survival of 78 months
after the diagnosis<sup><xref rid="r16" ref-type="bibr">16</xref></sup>.</p>
      <p>(Dr. Rubens Bonfiglioli; Dr. Andr&#xE9; Marun Lyrio)</p>
    </sec>
    <sec>
      <title>Comment</title>
      <p>After the necroscopic study, we can confirm the usual interstitial pneumonitis pattern,
shown by simple radiography and chest CT, DSS typical pulmonary alteration in advanced
stage. We also demonstrated the pericardial alterations that led to constrictive
pericarditis, which justifies part of the heart failure condition and confirms the CT
cardiac findings, despite of not having been identified by echocardiogram, a method
introduced in the literature as the test selected to identify pericardial effusions,
offering high sensitivity and specificity<sup><xref rid="r27" ref-type="bibr">27</xref></sup>.</p>
      <p>DCHF also had the interstitial fibrosis as anatomic substrate replacing myocardial
fibers. In this case, the increased interstitial collagen can be attributed to both
intramyocardial hyperplastic arteriolosclerosis, leading to relative muscle ischemia, or
the disease pathogenesis, which may have activated growth factors of fibroblasts of the
cardiac interstitium.</p>
      <p>Finally, pulmonary hypertension can be justified, in this case, by the heart impairment
resulting from DSS, but also, and primarily, by the severe hyperplastic arteriolopathy,
attributed to diffuse interstitial pulmonary fibrosis, justifying the dilation of right
chambers and pulmonary arteries, and tricuspid reflux found on echocardiogram, and which
also contributed to the patient's heart failure condition.</p>
      <p>In our case, unlike the epidemiological data, the patient was male and had older age at
the disease onset. It should also be noteworthy the rapid progression between the first
signs of the disease and death, which occurred after 8 - 9 months. Such fact can be
explained by the presence of several worse prognosis factors described throughout the
medical history: (1) rapid progression of skin disease, (2) cardiac involvement at
diagnosis, (3) presence of clinically evident pericarditis and pericardial effusion, and
(4) advanced pulmonary impairment. The necropsy findings coincide with the
anatomopathological descriptions in the literature, and classify the patient as having
rapidly progressive DSS in advanced stage.</p>
      <p>(Dr. Maria Aparecida Barone Teixeira; Academician Caio Bosquiero Zanetti)</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nihtyanova</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Coghlan</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Denton</surname>
              <given-names>CP</given-names>
            </name>
          </person-group>
          <article-title>Improved survival in systemic sclerosis is associated with better
ascertainment of internal organ disease: a retrospective cohort
study</article-title>
          <source>QJM</source>
          <year>2010</year>
          <volume>103</volume>
          <issue>2</issue>
          <fpage>109</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="pmid">19966313</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <source xml:lang="pt">Reumatologia diagn&#xF3;stico e tratamento</source>
          <edition>2&#xAA; ed</edition>
          <publisher-loc>Belo Horizonte</publisher-loc>
          <publisher-name>Medsi</publisher-name>
          <year>2001</year>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferri</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Valentini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cozzi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sebastiani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Michelassi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>La Montagna</surname>
              <given-names>G</given-names>
            </name>
            <etal>et al</etal>
            <collab>Systemic Sclerosis Study Group of the Italian Society of Rheumatology
(SIR-GSSSc)</collab>
          </person-group>
          <article-title>Systemic sclerosis: demographic, clinical, and serologic features and
survival in 1,102 Italian patients</article-title>
          <source>Medicine (Baltimore)</source>
          <year>2002</year>
          <volume>81</volume>
          <issue>2</issue>
          <fpage>139</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">11889413</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Fertig</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Somogyi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Medsger</surname>
              <given-names>TA</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Disease subsets, antinuclear antibody profile, and clinical features
in 127 French and 247 US adult patients with systemic sclerosis</article-title>
          <source>J Rheumatol</source>
          <year>2007</year>
          <volume>34</volume>
          <issue>1</issue>
          <fpage>104</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">17117486</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graf</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Hakendorf</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lester</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Patterson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>South Australian Scleroderma Register: autoantibodies as perspective
biomarkers of phenotype and outcome</article-title>
          <source>Int J Rheum Dis</source>
          <year>2012</year>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>102</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">22324953</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mierau</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moinzadeh</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Riemekasten</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Melchers</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Meurer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reichenberger</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Frequency of disease-associated and other nuclear autoantibodies in
patients of the German Network for Systemic Scleroderma: correlation with
characteristic clinical features</article-title>
          <source>Arthritis Res Ther</source>
          <year>2011</year>
          <volume>13</volume>
          <issue>5</issue>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reveille</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>DH</given-names>
            </name>
            <collab>American College of Rheumatology Ad Hoc Committee of Immunologic Testing
Guidelines</collab>
          </person-group>
          <article-title>Evidence-based guidelines for the use of immunologic tests:
anti-centromere, Scl-70, and nucleolar antibodies</article-title>
          <source>Arthritis Rheum</source>
          <year>2003</year>
          <volume>49</volume>
          <issue>3</issue>
          <fpage>399</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="pmid">12794797</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Manifesta&#xE7;&#xF5;es intrator&#xE1;cicas das doen&#xE7;as do col&#xE1;geno na
tomografia computadorizada de alta resolu&#xE7;&#xE3;o do t&#xF3;rax</article-title>
          <source>Radiol Bras</source>
          <year>2008</year>
          <volume>41</volume>
          <issue>3</issue>
          <fpage>189</fpage>
          <lpage>197</lpage>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devaraj</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Hansell</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Computed tomographic imaging in connective tissue
diseases</article-title>
          <source>Semin Respir Crit Care Med</source>
          <year>2007</year>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>389</fpage>
          <lpage>397</lpage>
          <pub-id pub-id-type="pmid">17764057</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woodhead</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wells</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Desai</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary complications of connective tissue diseases</article-title>
          <source>Clin Chest Med</source>
          <year>2008</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>149</fpage>
          <lpage>164</lpage>
          <pub-id pub-id-type="pmid">18267189</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ichikado</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Acute exacerbation of chronic interstitial pneumonia: high-resolution
computed tomography and pathologic findings</article-title>
          <source>J Thorac Imaging</source>
          <year>2007</year>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>221</fpage>
          <lpage>229</lpage>
          <pub-id pub-id-type="pmid">17721330</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meune</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vignaux</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kahan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Allanore</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Heart involvement in systemic sclerosis: Evolving concept and
diagnostic methodologies</article-title>
          <source>Arch Cardiovasc Dis</source>
          <year>2010</year>
          <volume>103</volume>
          <issue>1</issue>
          <fpage>46</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">20142120</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Champion</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>The heart in scleroderma</article-title>
          <source>Rheum Dis Clin North Am</source>
          <year>2008</year>
          <volume>34</volume>
          <issue>1</issue>
          <fpage>181</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="pmid">18329539</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deswal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Follansbee</surname>
              <given-names>WP</given-names>
            </name>
          </person-group>
          <article-title>Cardiac involvement in scleroderma</article-title>
          <source>Rheum Dis Clin North Am</source>
          <year>1996</year>
          <volume>22</volume>
          <issue>4</issue>
          <fpage>841</fpage>
          <lpage>860</lpage>
          <pub-id pub-id-type="pmid">8923599</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Follansbee</surname>
              <given-names>WP</given-names>
            </name>
          </person-group>
          <article-title>The cardiovascular manifestations of systemic sclerosis
(scleroderma)</article-title>
          <source>Curr Probl Cardiol</source>
          <year>1986</year>
          <volume>11</volume>
          <issue>5</issue>
          <fpage>241</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">3487417</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clements</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Furst</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Heart involvement in systemic sclerosis</article-title>
          <source>Clin Dermatol</source>
          <year>1994</year>
          <volume>12</volume>
          <issue>2</issue>
          <fpage>267</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="pmid">8076265</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leinwand</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Generalized scleroderma: report with autopsy findings</article-title>
          <source>Ann Intern Med</source>
          <year>1951</year>
          <volume>34</volume>
          <issue>1</issue>
          <fpage>226</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="pmid">14790551</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leinwand</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Duryee</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Scleroderma; based on a study of over 150 cases</article-title>
          <source>Ann Intern Med</source>
          <year>1954</year>
          <volume>41</volume>
          <issue>5</issue>
          <fpage>1003</fpage>
          <lpage>1041</lpage>
          <pub-id pub-id-type="pmid">13208044</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Devaux</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Amor</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Menkes</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Venot</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Nicardipine improves myocardial perfusion in systemic
sclerosis</article-title>
          <source>J Rheumatol</source>
          <year>1988</year>
          <volume>15</volume>
          <issue>9</issue>
          <fpage>1395</fpage>
          <lpage>1400</lpage>
          <pub-id pub-id-type="pmid">3264339</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kahan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Devaux</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Amor</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Menk&#xE8;s</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gu&#xE9;rin</surname>
              <given-names>F</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Pharmacodynamic effect of nicardipine on left ventricular function in
systemic sclerosis</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1990</year>
          <volume>15</volume>
          <issue>2</issue>
          <fpage>249</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="pmid">1689420</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janosik</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Osborn</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Kenney</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Zuckner</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Heart disease in systemic sclerosis</article-title>
          <source>Semin Arthritis Rheum</source>
          <year>1989</year>
          <volume>19</volume>
          <issue>3</issue>
          <fpage>191</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">2690346</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrias</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Scleroderma heart disease</article-title>
          <source>Conn Med</source>
          <year>1985</year>
          <volume>49</volume>
          <issue>4</issue>
          <fpage>214</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="pmid">3995955</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaine</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Primary pulmonary hypertension</article-title>
          <source>Lancet</source>
          <year>1998</year>
          <volume>352</volume>
          <issue>9129</issue>
          <fpage>719</fpage>
          <lpage>725</lpage>
          <pub-id pub-id-type="pmid">9729004</pub-id>
        </element-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Primary pulmonary hypertension</article-title>
          <source>N Engl J Med</source>
          <year>1997</year>
          <volume>336</volume>
          <issue>2</issue>
          <fpage>111</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">8988890</pub-id>
        </element-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Famularo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gasbarrone</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ialongo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marullo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Pictures in clinical medine. "Concretio cordis" and systemic
sclerosis</article-title>
          <source>Intern Med</source>
          <year>2009</year>
          <volume>48</volume>
          <issue>10</issue>
          <fpage>865</fpage>
          <lpage>866</lpage>
          <pub-id pub-id-type="pmid">19443988</pub-id>
        </element-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panchal</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Calcific constrictive pericarditis: a rare complication of CREST
syndrome</article-title>
          <source>Arthritis Rheum</source>
          <year>1996</year>
          <volume>39</volume>
          <issue>2</issue>
          <fpage>347</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="pmid">8849391</pub-id>
        </element-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Passen</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Echocardiography in pericardial disease</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2008</year>
          <volume>21</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">18165123</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f03" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>(A) Macroscopic view showing severe thickening of pericardial sac (asterisk) and
adherence between parietal and visceral pericardium (arrow); (B) Severe thickening of
visceral pericardium (asterisk).</p>
      </caption>
      <graphic xlink:href="abc-101-01-0e01-g03"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
